Optinose Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2025 to a ratio of 3.62, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the first quarter 2025. Average receivable collection period, for the Optinose Inc in Mar 31 2025 quarter, has decreased to 101 days, compared to 106 days, in the Dec 31 2024 quarter.

If we take a look into Healthcare sector 447 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2025 from 1465 to 3032.

What is Receivable Turnover Ratio?
What is Optinose Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

OPTN Receivables Turnover Ratio	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter
Y / Y Receivable Change	62.66 %	32.45 %	39.3 %	-5.92 %	-16.21 %
Y / Y Revenue Change	83.27 %	12.86 %	3.1 %	5.33 %	25.61 %
Receivable Turnover Ratio (TTM)	3.62	3.43	3.57	3.93	3.81
OPTN's Total Ranking	# 3032	# 1465	# 2703	# 2452	# 1002
Accounts Receivable average collection period days	101	106	102	93	96
Seq. Receivable Change	-12.31 %	-11.35 %	43 %	46.33 %	-28.6 %
Seq. Revenue Change	21.64 %	9.7 %	-0.26 %	37.7 %	-25.09 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 142
Healthcare Sector	# 448
Overall Market	# 3032

Receivable Turnover Ratio Statistics
High	Average	Low
168.73	-15.58	-572.41
(Dec 31 2019)		(Dec 31 2018)

OPTN Company Profile • Back to OPTN Efficiency Comparisons • Compare OPTN Receivables Turnover Ratio to its Competitors

Financial Statements
Optinose Inc 's Accounts Receivable	$ 23 Millions	Visit OPTN's Balance sheet
Optinose Inc 's Sales TTM	$ 91 Millions	Visit OPTN's Income Statement
Sources of OPTN's Revenues		Visit OPTN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
OPTN's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
OPTN's Growth Rates	OPTN's Roa	OPTN's Inventory Turnover Ratio	OPTN's Dividend Comparisons
OPTN's Profitability Ratios	OPTN's Roi	OPTN's Asset Turnover Ratio	OPTN's Dividend Growth
OPTN's Valuation Ratios	OPTN's Roe	OPTN's Financial Strength Ratios	OPTN's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2025	Receivable at quarter ending Mar 31 2025
National Healthcare Corp	10.70	$ 1,383.903 Millions	$ 129.386 Millions
International Stem Cell Corporation	10.69	$ 9.085 Millions	$ 0.850 Millions
Lftd Partners Inc	10.57	$ 35.782 Millions	$ 3.384 Millions
Strata Critical Medical Inc	10.49	$ 251.485 Millions	$ 23.981 Millions
Addus Homecare Corp	10.46	$ 1,211.521 Millions	$ 115.821 Millions
Sunlink Health Systems Inc	10.46	$ 31.774 Millions	$ 3.038 Millions
Myomo Inc	10.44	$ 38.496 Millions	$ 3.686 Millions
Rockwell Medical inc	10.34	$ 97.462 Millions	$ 9.422 Millions
Nexgel Inc	10.33	$ 8.670 Millions	$ 0.840 Millions
Utah Medical Products Inc	10.09	$ 38.898 Millions	$ 3.857 Millions
Sunshine Biopharma Inc	9.99	$ 36.235 Millions	$ 3.626 Millions
Inogen Inc	9.97	$ 339.960 Millions	$ 34.114 Millions
Immucell Corporation	9.94	$ 28.265 Millions	$ 2.844 Millions
Skinhealth Systems Inc	9.86	$ 321.515 Millions	$ 32.620 Millions
Travere Therapeutics Inc	9.85	$ 273.533 Millions	$ 27.783 Millions
Quidelortho Corp	9.76	$ 2,764.700 Millions	$ 283.200 Millions
Siga Technologies Inc	9.74	$ 120.330 Millions	$ 12.349 Millions
United Therapeutics Corporation	9.71	$ 2,994.100 Millions	$ 308.450 Millions
Nexalin Technology Inc	9.63	$ 0.131 Millions	$ 0.014 Millions
Sintx Technologies Inc	9.63	$ 2.569 Millions	$ 0.267 Millions
Surmodics Inc	9.57	$ 121.575 Millions	$ 12.708 Millions
Inspire Medical Systems inc	9.45	$ 839.173 Millions	$ 88.789 Millions
Alpha Pro Tech Ltd	9.39	$ 56.908 Millions	$ 6.063 Millions
Lensar Inc	9.25	$ 57.065 Millions	$ 6.169 Millions
Encompass Health Corporation	9.23	$ 5,512.600 Millions	$ 597.075 Millions
Twist Bioscience Corporation	9.16	$ 347.680 Millions	$ 37.936 Millions
Enanta Pharmaceuticals Inc	9.12	$ 64.463 Millions	$ 7.065 Millions
Acadia Pharmaceuticals Inc	9.07	$ 996.283 Millions	$ 109.791 Millions
Cervomed Inc	8.98	$ 9.308 Millions	$ 1.037 Millions
Genedx Holdings Corp	8.96	$ 329.462 Millions	$ 36.782 Millions

Date modified: 2026-08-29T17:41:32+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.